Playback speed
10 seconds
EHA 2024 Insights: Zanubrutinib vs. Acalabrutinib in B-cell Malignancies - An AE-Based Economic Analysis
By
Insights from 2024 EHA Annual Meeting
FEATURING
Talha Munir
By
Insights from 2024 EHA Annual Meeting
FEATURING
Talha Munir
57 views
July 8, 2024
Login to view comments.
Click here to Login